Assessment of the Frail Patient With End‐Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability
Frailty has emerged as a powerful predictor of clinical outcomes (e.g., decompensation, hospitalization, mortality) in patients with end‐stage liver disease (ESLD). It is therefore of paramount importance that all patients with ESLD undergo an assessment of frailty, to support life and death decisio...
Main Authors: | Felicity R Williams, Don Milliken, Jennifer C Lai, Matthew J Armstrong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1688 |
Similar Items
-
Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease
by: Januvi Jegatheswaran, et al.
Published: (2020-09-01) -
Relationship between dynapenia, sarcopenia and functional mobility in institutionalized frail elderly
by: Antonio V. Soares, et al.
Published: (2016-06-01) -
An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia
by: Young Joo Yang, et al.
Published: (2021-03-01) -
Sarcopenia in Inflammatory Bowel Disease: A NarrativeOverview
by: Amritpal Dhaliwal, et al.
Published: (2021-02-01) -
Physical activity in non-frail and frail older adults.
by: F Marijke Jansen, et al.
Published: (2015-01-01)